GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$16.3M
Doctors Paid
10,200
Transactions
28,935
2024 Total
$39,958
Payment Breakdown by Category
Research$12.0M (73.8%)
Consulting$1.4M (8.5%)
Travel$811,441 (5.0%)
Food & Beverage$662,114 (4.1%)
Royalty/License$13,888 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research
$12.0M
2,206 transactions
General
$4.3M
26,729 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 4
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Paarth Shah, M.d, M.D | Neurology | Gilbert, AZ | $4,812 | $0 |
| Prof. David Armstrong, Dpm, Phd, DPM, PHD | Podiatrist | Los Angeles, CA | $4,800 | $0 |
| Dr. Shalini Shah, Md, MD | Anesthesiology | Orange, CA | $4,791 | $0 |
| Jon Gertken, Md, MD | Physical Medicine & Rehabilitation | Saint Joseph, MO | $4,722 | $0 |
| Bianca Tribuzio, D.o, D.O | Physical Medicine & Rehabilitation | Jacksonville, FL | $4,491 | $0 |
| Maia Chakerian, Md, MD | Pain Medicine | Los Gatos, CA | $4,168 | $0 |
| Dr. Mark Ignatius, D.o, D.O | Physical Medicine & Rehabilitation | San Francisco, CA | $4,148 | $0 |
| Dr. David Clark, Md/Phd, MD/PHD | Pain Medicine | Palo Alto, CA | $4,113 | $0 |
| Jahangir Maleki, Md,Phd, MD,PHD | Neurology | Cleveland, OH | $4,038 | $0 |
| Johannes Van Den Anker, Md, MD | Neonatal-Perinatal Medicine | Washington, DC | $3,970 | $0 |
| Alan Kivitz, Md, MD | Rheumatology | Duncansville, PA | $3,900 | $0 |
| Dr. Geeta Nagpal, Md, MD | Anesthesiology | West Jordan, UT | $3,618 | $0 |
| Prof. Thomas Schnitzer, Md, Phd, MD, PHD | Neuromusculoskeletal Medicine, Sports Medicine | Chicago, IL | $3,600 | $0 |
| David Walega, Md, MD | Pain Medicine | Columbus, OH | $3,500 | $0 |
| Srinivasa Raja, M.d, M.D | Anesthesiology | Baltimore, MD | $3,413 | $0 |
| Dalia Elmofty | Interventional Pain Medicine | Chicago, IL | $3,407 | $0 |
| Dr. David Lesch, M.d, M.D | Neurology | Suwanee, GA | $3,214 | $0 |
| Christopher Gharibo, M.d, M.D | Anesthesiology | New York, NY | $3,175 | $0 |
| Dr. Michael King, D.d.s, D.D.S | General Practice | Jackson, TN | $3,124 | $0 |
| Eva Feldman, Md, MD | Electrodiagnostic Medicine | Ann Arbor, MI | $3,000 | $0 |
| Dr. David Armstrong, O.d, O.D | Optometrist | Roanoke, VA | $2,905 | $0 |
| Dr. Ali El-Mohandes, Md, MD | Interventional Pain Medicine | Hagerstown, MD | $2,836 | $0 |
| Dr. Isabel Huang, M.d, M.D | Physical Medicine & Rehabilitation | Dallas, TX | $2,782 | $0 |
| Charles Loprinzi, M.d, M.D | Medical Oncology | Rochester, MN | $2,767 | $0 |
| Humaira Hussain, Md, MD | Rheumatology | Voorhees, NJ | $2,691 | $0 |
Ad
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.